Gene:
MFHAS1
malignant fibrous histiocytoma amplified sequence 1

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  leucine rich repeat containing 65
Alternate Symbols:  LRRC65; MASL1
PharmGKB Accession Id: PA30773

Details

Cytogenetic Location: chr8 : p23.1 - p23.1
GP mRNA Boundary: chr8 : 8641999 - 8751131
GP Gene Boundary: chr8 : 8638999 - 8761131
Strand: minus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

Entrez Gene:
9258
OMIM:
605352
UCSC Genome Browser:
NM_004225
RefSeq RNA:
NM_004225
RefSeq Protein:
NP_004216
RefSeq DNA:
AC_000051
AC_000140
NC_000008
NG_009444
NT_077531
NW_001839122
NW_923873
UniProtKB:
MFHA1_HUMAN (Q9Y4C4)
Ensembl:
ENSG00000147324
GenAtlas:
MFHAS1
GeneCard:
MFHAS1
MutDB:
MFHAS1
ALFRED:
LO001717Q
HuGE:
MFHAS1
Comparative Toxicogenomics Database:
9258
ModBase:
Q9Y4C4
HumanCyc Gene:
HS07418
HGNC:
16982

Common Searches